134. Characterization of neuronal storage in the mucolipidosis type IV murine model

2009 ◽  
Vol 96 (2) ◽  
pp. S41-S42
Author(s):  
Susan Slaugenhaupt ◽  
Cyntia Curcio-Morelli ◽  
Florie Charles ◽  
Bhuvarahamurthy Venugopal ◽  
Yi Cao ◽  
...  
2007 ◽  
Vol 81 (5) ◽  
pp. 1070-1083 ◽  
Author(s):  
Bhuvarahamurthy Venugopal ◽  
Marsha F. Browning ◽  
Cyntia Curcio-Morelli ◽  
Andrea Varro ◽  
Norman Michaud ◽  
...  

2008 ◽  
Vol 93 (2) ◽  
pp. 38
Author(s):  
Susan Slaugenhaupt ◽  
Cyntia Curcio-Morelli ◽  
Bhuvaramurthy Venugopal ◽  
Andrea Varro ◽  
Norman Michaud ◽  
...  

Pathobiology ◽  
1976 ◽  
Vol 44 (1) ◽  
pp. 1-11 ◽  
Author(s):  
Nelly Livni ◽  
Cyril Legum

PEDIATRICS ◽  
1987 ◽  
Vol 79 (6) ◽  
pp. 953-959
Author(s):  
Naomi Amir ◽  
Joel Zlotogora ◽  
Gideon Bach

The clinical spectrum and developmental features of mucolipidosis type IV, a recessive lysosomal storage disorder, are presented. The evaluation was based on information from the clinical charts and information obtained from the families of 20 patients between the ages of 2 to 17 years. The clinical manifestations of the disease, profound psychomotor retardation and visual impairment, appear during the first year of life. Definitive diagnosis is made by electron microscopy which reveals storage organelles typical of the mucolipidoses. This study details, for the first time, the heterogeneity of the ophthalmologic features, specifically as pertains to the age of onset, degree and clinical course of the corneal opacities, and the retinal involvement. Although the top developmental level was found to be 12 to 15 months in language and motor function, the course of the disease is protracted for some children, who show only a slight improvement, and others, little if any deterioration despite the early infantile onset of the disease. This presentation provides guidelines for the clinical diagnosis of mucolipidosis type IV.


2013 ◽  
Vol 57 (1) ◽  
pp. 85-93 ◽  
Author(s):  
Anna Benini ◽  
Andrea Bozzato ◽  
Silvia Mantovanelli ◽  
Laura Calvarini ◽  
Edoardo Giacopuzzi ◽  
...  

1998 ◽  
Vol 95 (3) ◽  
pp. 1207-1212 ◽  
Author(s):  
R. Schiffmann ◽  
N. K. Dwyer ◽  
I. A. Lubensky ◽  
M. Tsokos ◽  
V. E. Sutliff ◽  
...  

PEDIATRICS ◽  
1988 ◽  
Vol 81 (4) ◽  
pp. 602-602
Author(s):  
RAPHAEL WEITZ ◽  
GERTRUDE KOHN

To the Editor.— We read with interest the presentation by Amir et al1 concerning the clinical spectrum and natural history of mucolipidosis type IV. Based on their experience with 20 patients, they try to provide guidelines for the clinical diagnosis of this lysosomal storage disease. It appears that severe visual impairment (due mainly to corneal opacities, myopia, and retinal degeneration) and psychomotor retardation are the cardinal features of this entity. However, corneal clouding and mild motor delay in their early stages may frequently be missed by even experienced pediatricians and we recently examined a 15-month-old boy who was referred to us for evaluation of a possible congenital myopathy.


Sign in / Sign up

Export Citation Format

Share Document